Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Advances in Behavioral Psychopharmacology"
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 October 2023 | Viewed by 4446
Special Issue Editor
Interests: antidepressants; behavioral psychopharmacology; chronic stress; depression; ketamine; mGlu receptors
Special Issue Information
According to WHO the global burden of mental disorders continues to grow, despite decades of detailed research in the field of neuroscience, using modern methods, including brain imaging techniques. Depression, bipolar disorder, schizophrenia, and other psychoses, dementia, developmental disorders, including autism, and other disorders related to abnormal emotions, thoughts, perceptions, and behavior still pose a huge global medical, social, and economic problem. Behavioral research using animal models of mental illnesses or screening tests used for finding potential drugs, help in the search for new forms of therapy. Animal models of mental disorders or at least some disease symptoms, although imperfect, also help to determine the pathomechanism of mental illnesses, the study of which is very difficult in patients. Substance use disorders including drugs addiction, related to the compulsive search and intake of addictive substances as a result of loss of control over the behavior are also a serious problem to public health. Here, research in the field of behavioral psychopharmacology also offers huge opportunities in the study of the mechanisms of these pathological states, as well as new therapeutic strategies. Despite great achievements in behavioral psychopharmacology, new efforts are still needed to cope with the growing problem of the spread of mental illness and modern techniques appear to be essential in dealing with these challenges.
In this Special Issue, we would like to gather experts in the field of behavioral psychopharmacology that focus on the discovery of new therapeutic agents and strategies and on the studies of the mechanisms of changes in animal behavior in response to environmental fluctuations and pharmacological interventions. Original research articles, as well as stimulating reviews that provide new interpretations of the up-to-date results and extant literature are highly welcome.
Dr. Agnieszka Pałucha-Poniewiera
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- behavioral models
- behavioral pharmacology
- drug abuse
- psychoactive drugs